The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Good morning! What would you buy if you earned $305 million in one year? Maybe I'd have a different color KitchenAid mixer for every season. Bird flu: ...

In a report released today, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

In a report released today, Glenn Chin from Seaport Global initiated coverage with a Buy rating on CarMax (KMX – Research Report) and a ...

The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president’s Florida golf courses is due to appear in court ...

Uttar Pradesh CM Yogi Adityanath highlighted the BJP's achievements in Haryana during a public meeting in Bhiwani, focusing on improved connectivity and new institutions. He criticized Congress ...

Get the latest Australian and world news covering breaking news and trending topics that educate, engage and entertain. Learn more about where you live, the language you speak, and how the country ...

Editorial writers explain these public health issues.

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.